Whilst a preference for a (shortened) period of triple therapy remains in the guidance, we recommend that dual therapy with oral anticoagulation and clopidogrel may be considered as an alternative to triple therapy in selected AF patients at low risk of stent thrombosis or
recurrent cardiac events.»
Individuals who are diabetic and have suffered a cardiac event may benefit from chelation therapy; the Trial to Access Chelation Therapy study which was funded by the National Institutes for Health suggests that chelation therapy may significantly reduce
a recurrent cardiac event.
Not exact matches
Does anhedonia and / or depressed mood predict
recurrent major adverse
cardiac events (MACEs) in people with acute coronary syndromes (ACS)?